The role of oxidative stress and autophagy in atherosclerosis

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Perrotta, Ida ^a   Aquila, Saveria ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; MOBILE SECURITY; SPACE DEBRIS;

CELLULAR EVENTS; GENETIC RISKS; GROWING BODIES; NEO-VASCULARIZATION; REACTIVE OXYGEN SPECIES; SMOOTH MUSCLE CELLS; THERAPEUTIC TARGETS; VASCULAR DISEASE;

DISEASES;

CHOLESTEROL; LIPID; LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; NOX4 PROTEIN, HUMAN;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; AUTOPHAGY; CELL PROLIFERATION; DISEASE COURSE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; AORTA; CYTOLOGY; METABOLISM; PATHOLOGY; SMOOTH MUSCLE CELL;

AORTA; ATHEROSCLEROSIS; AUTOPHAGY; HUMANS; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84926314569     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/130315     Document Type: Article

References (106)

1. K. M. Holmström and T. Finkel, "Cellular mechanisms and physiological consequences of redox-dependent signalling", Nature Reviews Molecular Cell Biology, vol. 15, no. 6, pp. 411-421, 2014.
2. A. Agarwal, S. Gupta, and S. Sikka, "The role of free radicals and antioxidants in reproduction", Current Opinion in Obstetrics & Gynecology, vol. 18, no. 3, pp. 325-332, 2006.
3. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, "Diabetes, oxidative stress, and antioxidants: a review", Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24-38, 2003.
4. I. Peluso, G. Morabito, L. Urban, F. Ioannone, and M. Serafini, "Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst", Endocrine, Metabolic and Immune Disorders-Drug Targets, vol. 12, no. 4, pp. 351-360, 2012.
5. M. Rosenblat and M. Aviram, "Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E", Atherosclerosis, vol. 160, no. 1, pp. 69-80, 2002.
6. U. Rueckschloss, N. Duerrschmidt, and H. Morawietz, "NADPH oxidase in endothelial cells: Impact on atherosclerosis", Antioxidants & Redox Signaling, vol. 5, no. 2, pp. 171-180, 2003.
7. M. K. Cathcart, "Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 23-28, 2004.
8. G. Filomeni, D. De Zio, and F. Cecconi, "Oxidative stress and autophagy: the clash between damage and metabolic needs", Cell Death and Differentiation, vol. 22, no. 3, pp. 377-388, 2015.
9. S. Y. Ren and X. Xu, "Role of autophagy inmetabolic syndrome-associated heart disease", Biochimica et Biophysica Acta, vol. 1852, no. 2, pp. 225-231, 2015.
10. Y. S. Rajawat and I. Bossis, "Autophagy in aging and in neurodegenerative disorders", Hormones, vol. 7, no. 1, pp. 46-61, 2008.
11. K. Suzuki, T. Kirisako, Y. Kamada, N. Mizushima, T. Noda, and Y. Ohsumi, "The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation", The EMBO Journal, vol. 20, no. 21, pp. 5971-5981, 2001.
12. W.-L. Yen and D. J. Klionsky, "Atg27 is a second transmembrane cycling protein", Autophagy, vol. 3, no. 3, pp. 254-256, 2007.
13. D. J. Klionsky, F. C. Abdalla, H. Abeliovich et al., "Guidelines for the use and interpretation of assays for monitoring autophagy", Autophagy, vol. 8, no. 4, pp. 445-544, 2012.
14. J. Ezaki, N. Matsumoto, M. Takeda-Ezaki et al., "Liver autophagy contributes to themaintenance of blood glucose and amino acid levels", Autophagy, vol. 7, no. 7, pp. 727-736, 2011.
15. R. Singh, S. Kaushik, Y. Wang et al., "Autophagy regulates lipid metabolism", Nature, vol. 458, no. 7242, pp. 1131-1135, 2009.
16. R. Singh, "Autophagy and regulation of lipid metabolism", Results and Problems in Cell Differentiation, vol. 52, pp. 35-46, 2010.
17. I. Sergin and B. Razani, "Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis", Trends in Endocrinology & Metabolism, vol. 25, no. 5, pp. 225-234, 2014.
18. R. Singh and A. M. Cuervo, "Lipophagy: connecting autophagy and lipid metabolism", International Journal of Cell Biology, vol. 2012, Article ID282041, 12 pages, 2012.
19. J. Davignon and P. Ganz, "Role of endothelial dysfunction in atherosclerosis", Circulation, vol. 109, no. 23, pp. III27-III32, 2004.
20. -/- mice", Journal of Clinical Investigation, vol. 118, no. 1, pp. 183-194, 2008.
21. I. M. Fearon and S. P. Faux, "Oxidative stress and cardiovascular disease: novel tools give (free) radical insight", Journal of Molecular and Cellular Cardiology, vol. 47, no. 3, pp. 372-381, 2009.
22. L. Van Heerebeek, C. Meischl, W. Stooker, C. J. L. M. Meijer, H. W. M. Niessen, and D. Roos, "NADPH oxidase (s): new source (s) of reactive oxygen species in the vascular system?" Journal of Clinical Pathology, vol. 55, no. 8, pp. 561-568, 2002.
23. B. Lassègue and K. K. Griendling, "NADPHoxidases: Functions and pathologies in the vasculature", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 653-661, 2010.
24. A. R. Cross and A. W. Segal, "The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems", Biochimica et Biophysica Acta: Bioenergetics, vol. 1657, no. 1, pp. 1-22, 2004.
25. A. Cave, D. Grieve, S. Johar, M. Zhang, and A. M. Shah, "NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology", Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 360, no. 1464, pp. 2327-2334, 2005.
26. J. M. Li and A. M. Shah, "ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy", Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S221-S226, 2003.
27. A. Konior, A. Schramm, M. Czesnikiewicz-Guzik, and T. J. Guzik, "NADPH oxidases in vascular pathology", Antioxidants and Redox Signaling, vol. 20, no. 17, pp. 2794-2814, 2014.
28. N. R. Madamanchi and M. S. Runge, "NADPH oxidases and atherosclerosis: unraveling the details", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 1, pp. H1-H2, 2010.
29. W. Yin and E. O. Voit, "Function and design of the Nox1 system in vascular smooth muscle cells", BMC Systems Biology, vol. 7, article 20, 2013.
30. S. Pendyala, P. V. Usatyuk, I. A. Gorshkova, J. G. N. Garcia, and V. Natarajan, "Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins", Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 841-860, 2009.
31. B. Lassègue, A. San Martín, and K. K. Griendling, "Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system", Circulation Research, vol. 110, no. 10, pp. 1364-1390, 2012.
32. E. Schulz and T. Münzel, "NOX5, a new 'radical' player in human atherosclerosis?" Journal of the American College of Cardiology, vol. 52, no. 22, pp. 1810-1812, 2008.
33. A. Dikalova, R. Clempus, B. Lassègue et al., "Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice", Circulation, vol. 112, no. 17, pp. 2668-2676, 2005.
34. M. Y. Lee, A. S. Martin, P. K. Mehta et al., "Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 480-487, 2009.
35. A. L. Sheehan, S. Carrell, B. Johnson, B. Stanic, B. Banfi, and F. J. Miller, "Role for Nox1 NADPH oxidase in atherosclerosis", Atherosclerosis, vol. 216, no. 2, pp. 321-326, 2011.
36. S. P. Gray, E. Di Marco, J. Okabe et al., "NADPH Oxidase 1 plays a key role in diabetesmellitus-accelerated atherosclerosis", Circulation, vol. 127, no. 18, pp. 1888-1902, 2013.
37. G. Gavazzi, B. Banfi, C. Deffert et al., "Decreased blood pressure in NOX1-deficient mice", FEBS Letters, vol. 580, no. 2, pp. 497-504, 2006.
38. M. Thomas, D. Gavrila, M. L. McCormick et al., "Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice", Circulation, vol. 114, no. 5, pp. 404-413, 2006.
39. S. Xu, A. S. Shriver, D. K. Jagadeesha et al., "Increasedexpression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9", Journal of Vascular Research, vol. 49, no. 3, pp. 242-248, 2012.
40. A. K. Chan, A. Kalmes, S. Hawkins, G. Daum, and A. W. Clowes, "Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery", Journal of Vascular Surgery, vol. 37, no. 3, pp. 644-649, 2003.
41. D. K. Jagadeesha, M. Takapoo, B. Banfi, R. C. Bhalla, and F. J. Miller Jr., "Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration", Cardiovascular Research, vol. 93, no. 3, pp. 406-413, 2012.
42. S.-L. Chan and G. L. Baumbach, "Nox2 deficiency prevents hypertension-induced vascular dysfunction and hypertrophy in cerebral arterioles", International Journal of Hypertension, vol. 2013, Article ID 793630, 8 pages, 2013.
43. P. Sukumar, H. Viswambharan, H. Imrie et al., "Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction", Diabetes, vol. 62, no. 6, pp. 2130-2134, 2013.
44. Y.-H. You, S. Okada, S. Ly et al., "Role of Nox2 in diabetic kidney disease", The American Journal of Physiology-Renal Physiology, vol. 304, no. 7, pp. F840-F848, 2013.
45. L. Loffredo, F. Martino, R. Carnevale et al., "Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction", Journal of Pediatrics, vol. 161, pp. 1004-1009, 2012.
46. -/- mice", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 1, pp. H24-H32, 2010.
47. -/- mice", Cardiovascular Research, vol. 94, no. 1, pp. 20-29, 2012.
48. T. J. Guzik, J. Sadowski, B. Guzik et al., "Coronary artery superoxide production and nox isoform expression in human coronary artery disease", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 333-339, 2006.
49. F. Chen, S. Haigh, S. Barman, and D. J. R. Fulton, "From form to function: the role of Nox4 in the cardiovascular system", Frontiers in Physiology, vol. 3, article 412, 2012.
50. D. Sorescu, D. Weiss, B. Lassègue et al., "Superoxide production and expression of Nox family proteins in human atherosclerosis", Circulation, vol. 105, no. 12, pp. 1429-1435, 2002.
51. B. Stanic, D. Pandey, D. J. Fulton, and F. J. Miller Jr., "Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 10, pp. 2452-2460, 2012.
52. K. Schröder, K. Wandzioch, I. Helmcke, and R. P. Brandes, "Nox4 acts as a switch between differentiation and proliferation in preadipocytes", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 2, pp. 239-245, 2009.
53. H. Ding, D. Li, Y. Zhang et al., "Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells", Current Pharmaceutical Biotechnology, vol. 14, no. 12, pp. 1009-1015, 2014.
54. R. E. Clempus, D. Sorescu, A. E. Dikalova et al., "Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 42-48, 2007.
55. S. Xu, A. H. Chamseddine, S. Carrell, and F. J. Miller, "Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques", Redox Biology, vol. 2, no. 1, pp. 642-650, 2014.
56. I. Diebold, A. Petry, M. Burger, J. Hess, and A. Görlach, "NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II", Molecular Biology of the Cell, vol. 22, no. 22, pp. 4424-4434, 2011.
57. R. E. Clempus and K. K. Griendling, "Reactive oxygen species signaling in vascular smooth muscle cells", Cardiovascular Research, vol. 71, no. 2, pp. 216-225, 2006.
58. I. Perrotta, A. Sciangula, E. Perrotta, G. Donato, and M. Cassese, "Ultrastructural analysis and electron microscopic localization of Nox4 in healthy and atherosclerotic human aorta", Ultrastructural Pathology, vol. 35, no. 1, pp. 1-6, 2011.
59. J. Hwang, M. H. Ing, A. Salazar et al., "Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation", Circulation Research, vol. 93, no. 12, pp. 1225-1232, 2003.
60. C. Goettsch, W. Goettsch, A. Arsov, L. C. Hofbauer, S. R. Bornstein, and H. Morawietz, "Long-term cyclic strain downregulates endothelial Nox4", Antioxidants & Redox Signaling, vol. 11, no. 10, pp. 2385-2397, 2009.
61. B. Lassègue and R. E. Clempus, "Vascular NAD (P) H oxidases: Specific features, expression, and regulation", The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 285, no. 2, pp. R277-R297, 2003.
62. S. Ullevig, Q. Zhao, C. F. Lee, H. S. Kim, D. Zamora, and R. Asmis, "NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 415-426, 2012.
63. C. F. Lee, M. Qiao, K. Schröder, Q. Zhao, and R. Asmis, "Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized lowdensity lipoprotein-induced macrophage death", Circulation Research, vol. 106, no. 9, pp. 1489-1497, 2010.
64. T. J. Guzik, W. Chen, M. C. Gongora et al., "Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease", Journal of the American College of Cardiology, vol. 52, no. 22, pp. 1803-1809, 2008.
65. A. Manea, S. A. Manea, I. C. Florea, C. M. Luca, and M. Raicu, "Positive regulation of NADPH oxidase 5 by proinflammatoryrelated mechanisms in human aortic smoothmuscle cells", Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1497-1507, 2012.
66. Q. Zhang, P. Malik, D. Pandey et al., "Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 9, pp. 1627-1633, 2008.
67. X. Xing, J. Baffic, and C. P. Sparrow, "LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transitionmetal ions", Journal of Lipid Research, vol. 39, no. 11, pp. 2201-2208, 1998.
68. M. Aviram, M. Rosenblat, A. Etzioni, and R. Levy, "Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein", Metabolism: Clinical and Experimental, vol. 45, no. 9, pp. 1069-1079, 1996.
69. E. A. Bey and M. K. Cathcart, "In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes", Journal of Lipid Research, vol. 41, no. 3, pp. 489-495, 2000.
70. M. K. Cathcart, "Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 23-28, 2004.
71. R. A. Nixon, "The role of autophagy in neurodegenerative disease", Nature Medicine, vol. 19, no. 8, pp. 983-997, 2013.
72. J.-M. Yuk, T. Yoshimori, and E.-K. Jo, "Autophagy and bacterial infectious diseases", Experimental and Molecular Medicine, vol. 44, no. 2, pp. 99-108, 2012.
73. C. Grose, "Autophagy during common bacterial and viral infections of children", Pediatric Infectious Disease Journal, vol. 29, no. 11, pp. 1040-1042, 2010.
74. R. Mathew, V. Karantza-Wadsworth, and E. White, "Role of autophagy in cancer", Nature Reviews Cancer, vol. 7, no. 12, pp. 961-967, 2007.
75. D. M. Schrijvers, G. R. Y. De Meyer, and W. Martinet, "Autophagy in atherosclerosis: a potential drug target for plaque stabilization", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 12, pp. 2787-2791, 2011.
76. R. Kiffin, U. Bandyopadhyay, and A. M. Cuervo, "Oxidative stress and autophagy", Antioxidants & Redox Signaling, vol. 8, no. 1-2, pp. 152-162, 2006.
77. Z. Ding, S. Liu, X. Wang, M. Khaidakov, Y. Dai, and J. L. Mehta, "Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis", Scientific Reports, vol. 3, article 1077, 2013.
78. G. R. Y. De Meyer and W. Martinet, "Autophagy in the cardiovascular system", Biochimica et Biophysica Acta, vol. 1793, no. 9, pp. 1485-1495, 2009.
79. J. K. Salabei, A. Balakumaran, J. C. Frey, P. J. Boor, M. Treinen-Moslen, and D. J. Conklin, "Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy", Toxicology and Applied Pharmacology, vol. 262, no. 3, pp. 265-272, 2012.
80. W. Martinet, M. De Bie, D. M. Schrijvers, G. R. Y. De Meyer, A. G. Herman, and M. M. Kockx, "7-Ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 12, pp. 2296-2301, 2004.
81. -/- mice", Scientific Reports, vol. 4, article 5519, 2014.
82. B. Razani, C. Feng, T. Coleman et al., "Autophagy links inflammasomes to atherosclerotic progression", Cell Metabolism, vol. 15, no. 4, pp. 534-544, 2012.
83. X. Liao, J. C. Sluimer, Y. Wang et al., "Macrophage autophagy plays a protective role in advanced atherosclerosis", Cell Metabolism, vol. 15, no. 4, pp. 545-553, 2012.
84. X. Le Guezennec, A. Brichkina, Y.-F. Huang, E. Kostromina, W. Han, and D. V. Bulavin, "Wip1-dependent regulation of autophagy, obesity, and atherosclerosis", Cell Metabolism, vol. 16, no. 1, pp. 68-80, 2012.
85. M. C. Maiuri, G. Grassia, A. M. Platt, R. Carnuccio, A. Ialenti, and P. Maffia, "Macrophage autophagy in atherosclerosis", Mediators of Inflammation, vol. 2013, Article ID 584715, 14 pages, 2013.
86. W. Martinet and G. R. Y. De Meyer, "Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential", Circulation Research, vol. 104, no. 3, pp. 304-317, 2009.
87. M. Beller, K. Thiel, P. J. Thul, and H. Jäckle, "Lipid droplets: a dynamic organellemoves into focus", FEBS Letters, vol. 584, no. 11, pp. 2176-2182, 2010.
88. K. Liu and M. J. Czaja, "Regulation of lipid stores and metabolism by lipophagy", Cell Death and Differentiation, vol. 20, no. 1, pp. 3-11, 2013.
89. M. Ouimet, V. Franklin, E. Mak, X. Liao, I. Tabas, and Y. L. Marcel, "Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase", Cell Metabolism, vol. 13, no. 6, pp. 655-667, 2011.
90. P. Ylä-Anttila, H. Vihinen, E. Jokitalo, and E. L. Eskelinen, "Monitoring autophagy by electron microscopy in Mammalian cells", Methods in Enzymology, vol. 452, pp. 143-164, 2009.
91. E.-L. Eskelinen, F. Reggiori, M. Baba, A. L. Kovács, and P. O. Seglen, "Seeing is believing: the impact of electron microscopy on autophagy research", Autophagy, vol. 7, no. 9, pp. 935-956, 2011.
92. E. Tasdemir, L. Galluzzi, M. C. Maiuri et al., "Methods for assessing autophagy and autophagic cell death", Methods in Molecular Biology, vol. 445, pp. 29-76, 2008.
93. M. M. Kockx, G. R. Y. De Meyer, J. Muhring, W. Jacob, H. Bult, and A. G. Herman, "Apoptosis and related proteins in different stages of human atherosclerotic plaques", Circulation, vol. 97, no. 23, pp. 2307-2315, 1998.
94. S. Verheye, W. Martinet, M. M. Kockx et al., "Selective clearance of macrophages in atherosclerotic plaques by autophagy", Journal of the American College of Cardiology, vol. 49, no. 6, pp. 706-715, 2007.
95. I. Perrotta, "The use of electron microscopy for the detection of autophagy in human atherosclerosis", Micron, vol. 50, pp. 7-13, 2013.
96. G. Wu, G. Wei, J. Huang, S. Pang, L. Liu, and B. Yan, "Decreased gene expression of LC3 in peripheral leucocytes of patients with coronary artery disease", European Journal of Clinical Investigation, vol. 41, no. 9, pp. 958-963, 2011.
97. W. Martinet and G. R. Y. De Meyer, "Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality?" Circulation Research, vol. 100, no. 6, pp. 751-753, 2007.
98. W. Martinet, M. W. M. Knaapen, M. M. Kockx, and G. R. Y. De Meyer, "Autophagy in cardiovascular disease", Trends in Molecular Medicine, vol. 13, no. 11, pp. 482-491, 2007.
99. Y. Grishchuk, V. Ginet, A. C. Truttmann, P. G. H. Clarke, and J. Puyal, "Beclin 1-independent autophagy contributes to apoptosis in cortical neurons", Autophagy, vol. 7, no. 10, pp. 1115-1131, 2011.
100. N. C. McKnight, Y. Zhong, M. S. Wold et al., "Beclin1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex", PLoS Genetics, vol. 10, no. 10, Article ID e1004626, 2014.
101. W. J. S. De Villiers and E. J. Smart, "Macrophage scavenger receptors and foamcell formation", Journal of Leukocyte Biology, vol. 66, no. 5, pp. 740-746, 1999.
102. Z. Ding, X. Wang, L. Schnackenberg et al., "Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7g", International Journal of Cardiology, vol. 168, no. 2, pp. 1378-1385, 2013.
103. W. Martinet, D. M. Schrijvers, J.-P. Timmermans, and H. Bult, "Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells", British Journal of Pharmacology, vol. 154, no. 6, pp. 1236-1246, 2008.
104. S. J. Chapple, X. Cheng, and G. E. Mann, "Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease", Redox Biology, vol. 1, no. 1, pp. 319-331, 2013.
105. B. G. Hill, P. Haberzettl, Y. Ahmed, S. Srivastava, and A. Bhatnagar, "Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells", Biochemical Journal, vol. 410, no. 3, pp. 525-534, 2008.
106. C. F. Michiels, D. M. Schrijvers, G. R. Y. De Meyer, and W. Martinet, "The role of autophagy in atherosclerosis", in Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, and Infection, M. A. Hayat, Ed., vol. 1 of Molecular Mechanisms, pp. 80-89, Elsevier, 2013.